Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06687759
PHASE1

A Study of Calderasib (MK-1084) Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

The purpose of this study is to learn what happens to calderasib in a healthy person's body over time and how it is cleared from the body.

Official title: A Phase 1 Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]MK-1084 in Healthy Adult Participants

Key Details

Gender

MALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

8

Start Date

2024-06-26

Completion Date

2024-08-07

Last Updated

2026-04-13

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

[14C]Calderasib

Oral administration

Locations (1)

Fortea CRU Madison (Site 0001)

Madison, Wisconsin, United States